Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Unknown 3

Sponsor Class

OTHER_GOV 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 4Pancreatic Neoplasms 3Hypertension, Portal 3Colorectal Neoplasms 2Stomach Neoplasms 1Melanoma 1Liver Neoplasms 1Liver Cirrhosis 1Gastrointestinal Neoplasms 1Digestive System Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Propranolol 3Portasystemic Shunt, Transjugular Intrahepatic 2tremelimumab 1durvalumab 1Radiofrequency Ablation 1Liver Transplantation 1Hepatectomy 1Diagnostic Imaging 1Carvedilol 1Bevacizumab 16-acetylaminocaproic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Hypertension, Portal × Propranolol × Gastrointestinal × Clear all
NCT01451658 2019-09-04

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT01970748 2019-08-30

P-HCC

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT01298284 2011-06-15

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡